Prescribing information for lecanemab features a boxed warning about likely challenges affiliated with ARIA. Ideal use recommendations talk about techniques to minimize ARIA threat, as does AAN steerage. The extension study also evaluated CLARITY Advert contributors who experienced a delayed get started (individuals that switched from placebo to lecanemab once https://elenad197cnx7.webdesign96.com/profile